Inappropriate Antibiotic Use in Zimbabwe in the COVID-19 Era: A Perfect Recipe for Antimicrobial Resistance.

COVID-19 antimicrobial resistance antimicrobial stewardship

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
13 Feb 2022
Historique:
received: 24 01 2022
revised: 07 02 2022
accepted: 10 02 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

The global COVID-19 pandemic has resulted in an upsurge in antimicrobial use. The increase in use is multifactorial, and is particularly related to the empirical treatment of SARS-CoV-2 and suspected coinfections with antimicrobials and the limited quality of diagnostics to differentiate viral and bacterial pneumonia. The lack of clear clinical guidelines across a wide range of settings, and the inadequacy of public health sectors in many countries, have contributed to this pattern. The increased use of antimicrobials has the potential to increase incidences of antimicrobial resistance, especially in low-resource countries such as Zimbabwe already grappling with multidrug-resistant micro-organism strains. By adopting the antimicrobial stewardship principles of the correct prescription and optimised use of antimicrobials, as well as diagnostic stewardship, revamping regulatory oversight of antimicrobial surveillance may help limit the occurrence of antimicrobial resistance during this pandemic.

Identifiants

pubmed: 35203846
pii: antibiotics11020244
doi: 10.3390/antibiotics11020244
pmc: PMC8868384
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Antibiotics (Basel). 2021 Dec 14;10(12):
pubmed: 34943743
Vaccines (Basel). 2021 Mar 12;9(3):
pubmed: 33809002
BMJ. 2021 Nov 17;375:n2754
pubmed: 34789457
Pan Afr Med J. 2020 Aug 11;35(Suppl 2):143
pubmed: 33193958
BMC Infect Dis. 2019 Aug 27;19(1):746
pubmed: 31455256
Lancet. 2022 Feb 12;399(10325):606-607
pubmed: 35065701
Public Health Pract (Oxf). 2021 Nov;2:100086
pubmed: 34494007
Global Health. 2020 Jun 24;16(1):51
pubmed: 32580728
J Antimicrob Chemother. 2007 Aug;60(2):214-36
pubmed: 17550892
Antibiotics (Basel). 2020 Dec 14;9(12):
pubmed: 33327430
Clin Microbiol Infect. 2021 Feb;27(2):204-209
pubmed: 33144202
Bull World Health Organ. 2020 Jul 1;98(7):442-442A
pubmed: 32742026
Public Health Pract (Oxf). 2020 Nov;1:100058
pubmed: 34173583
Antibiotics (Basel). 2021 Oct 27;10(11):
pubmed: 34827245
Int J Infect Dis. 2021 Mar;104:250-254
pubmed: 33434666
J Antimicrob Chemother. 2020 Dec 1;75(12):3413-3416
pubmed: 32830266
BMJ Glob Health. 2021 Nov;6(11):
pubmed: 34836911
J Glob Antimicrob Resist. 2021 Jun;25:5-7
pubmed: 33662647
BMC Infect Dis. 2021 Nov 8;21(1):1144
pubmed: 34749645
Clin Chem. 2021 Dec 30;68(1):75-82
pubmed: 34969099
Trans R Soc Trop Med Hyg. 2021 Oct 1;115(10):1122-1129
pubmed: 33772597
J Trop Pediatr. 2001 Aug;47(4):230-8
pubmed: 11523765
Int J Antimicrob Agents. 2021 Apr;57(4):106324
pubmed: 33746045
Clin Microbiol Infect. 2017 Nov;23(11):793-798
pubmed: 28882725
Lancet. 2020 Oct 10;396(10257):1050-1053
pubmed: 33007218
Am J Trop Med Hyg. 2020 Oct;103(4):1360-1363
pubmed: 32815510
Nat Hum Behav. 2020 Jun;4(6):577-587
pubmed: 32493967
J Infect Public Health. 2021 May;14(5):555-560
pubmed: 33848884
J Antimicrob Chemother. 2021 Jul 26;76(12 Suppl 2):ii68-ii78
pubmed: 34312659
Elife. 2021 Feb 16;10:
pubmed: 33588991
J Infect Public Health. 2021 Jan;14(1):53-60
pubmed: 33341485
Clin Infect Dis. 2021 May 18;72(10):e542-e544
pubmed: 32857832
Lancet Infect Dis. 2021 Jun;21(6):e144
pubmed: 33275941
Trop Med Health. 2021 Jun 23;49(1):51
pubmed: 34162445
Pneumonia (Nathan). 2021 Apr 25;13(1):5
pubmed: 33894790
AIDS Behav. 2020 Nov;24(11):3014-3016
pubmed: 32488551
Trop Med Int Health. 2020 Aug;25(8):962-975
pubmed: 32418294
Eur J Clin Microbiol Infect Dis. 2021 Dec;40(12):2543-2550
pubmed: 34292453

Auteurs

Itai Chitungo (I)

Chemical Pathology Unit, Department of Medical Laboratory Sciences, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

Tafadzwa Dzinamarira (T)

School of Health Systems & Public Health, University of Pretoria, Pretoria 0002, South Africa.
ICAP at Columbia University, Harare, Zimbabwe.

Tinashe K Nyazika (TK)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.

Helena Herrera (H)

School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2UP, UK.

Godfrey Musuka (G)

School of Health Systems & Public Health, University of Pretoria, Pretoria 0002, South Africa.

Grant Murewanhema (G)

Unit of Obstetrics and Gynaecology, Department of Primary Health Care Sciences, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

Classifications MeSH